Might Olfactory Dysfunction be a Marker of Early Alzheimer's Disease?
Lancet 355:84-85, Burns,A., 2000
Amnesic Syndrome with Bilateal Mesial Temporal Lobe Involvement in Hashimoto's Encephalopathy
Neurol 54:737-739, McCabe,D.J.H.,et al, 2000
Estrogen for Alzheimer's Disease in Women, Randomized, Double-Blind, Placebo-Controlled Trial
Neurol 54:295-301, Henderson,V.W.,et al, 2000
Autosomal Dominant Diffuse Leukoencephalopathy with Neuroaxonal Spheroids
Neurol 54:463-468, van der Knaap,M.S.,et al, 2000
The Nonmotor Problems of Parkinson's Disease
The Neurologist 6:18-27, Friedman,J.H.&Fernandez,H.H., 2000
Diffusion-Weighted MRI in Vascular Dementia
Neurol 54:83-89, Choi,S.H.,et al, 2000
Diagnosis and Treatment of Intravascular Lymphomatosis
ArchNeurol 57:374-377, Baumann,T.P.,et al, 2000
An 80-Year-Old Man With Memory Loss
JAMA 283:1046-1053, Larson,E.B., 2000
Using Serial Registered Brain Magnetic Resonance Imaging to Measure Disease Progression in Alzheimer Disease
ArchNeurol 57:339-344, Fox,N.C.,et al, 2000
Diagnostic Accuracy of Dementia with Lewy Bodies
ArchNeurol 57:347-351, Hohl,U.,et al, 2000
Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease
JAMA 283:1007-1015,1055, Mulnar,R.A.,et al, 2000
Clinicopath Conf,Cerebral Amyloid Angiogpathy and Giant-Cell Inflammatory Reaction to Beta 4-Amyloid and Vasculitis, Case 10-2000
NEJM 342:957-965, , 2000
Progression of Parkinsonian Signs in Alzheimer's Disease
Neurol 54:1284-1289, Wilson,R.S.,et al, 2000
Practice Parameter: Risk of Driving and Alzheimer's Disease (An Evidence-Based Review)
Neurol 54:2205-2211, Dubinsky,R.M.,et al, 2000
The Preclinical Phase of Alzheimer Disease
Arch Neurol 57:808-813, Elias,M.F.,et al, 2000
Reduced Prevalence of AD in Users of NSAIDs and H2 Receptor Antagonists
Neurol 54:2066-2071, Anthony,J.C.,et al, 2000
Hypersexuality in Patients with Dementia: Possible Response to Cimetidine
Neurol 54:2024, Wiseman,S.V.,et al, 2000
The Pulvinar Sign on Magnetic Resonance Imaging in Variant Creutzfeldt-Jakob Disease
Lancet 355:1412-1418,1384, Zeidler,M.,et al, 2000
The Relative Frequency of "Dementia of Unknown Etiology" Increases With Age and Is nearly 50% in Nonagenarians
Arch Neurol 57:713-719, Crystal,H.A.,et al, 2000
Diagnosis of New Variant Creutzfeldt-Jakob Disease
Ann Neurol 47:575-582, Will,R.G.,et al, 2000
Clinicopath Conf., Pick's Disease, Case 11-2000
NEJM 342:1110-1117, , 2000
Smoking and Dementia in Male British Doctors: Prospective Study
BMJ 320:1097-1102,1087, Doll,R.,et al, 2000
Highly Active Antiretroviral Therapy for Patients with AIDS Dementia Complex: Effect on MR Imaging Findings and Clinical Course
AJNR 21:670-678, Thurnher,M.M.,et al, 2000
Variability of the Mini-Mental State Examination in Dementia
Neurol 54:1538-1539, Doraiswamy,P.M.&Kaiser,L., 2000
Progressive Dementia and Gait Disorder in a 78 Year Old Woman
JNNP 68:526-531, Tagliati,M.,et al, 2000
Life-Threatening Tinnitus
Lancet 356:308, Javaheri,S. et al, 2000
Survival in End-Stage Dementia Following Acute Illness
JAMA 284: 47-52, 87, Morrison,R.S. & Siu,A.L., 2000
Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000
Inborn Errors of Metabolism as a Cause of Neurological Disease in Adults: An Approach to Investigation
JNNP 69: 5-12, Gray,R.G.F. et al, 2000
Risk of Acquiring Creutzfeldt-Jakob Disease from Blood Transfusions: Systematic Review of Case-Control Studies
BMJ 321:17-19, Wilson,K. et al, 2000
FLAIR MRI in sporadic Creutzfeldt-Jakob Disease
Neurol 55:147-148, Vrancken,A.F.J.E. et al, 2000
Patterns of Brain Activation in People at Risk for Alzheimer's Disease
NEJM 343:450-456,502, Bookheimer,S.Y. et al, 2000
14-3-3 Testing in Diagnosing Creutzfeldt-Jakob Disease
Neurol 55:514-516, Lemstra,A.W. et al, 2000
What Contributes to Quality of Life in Patients with Parkinson's Disease?
JNNP 69:308-312,289, Schrag,A. et al, 2000
Incidence and Prevalence of Neurological Disorders Associated with HIV Since the Introduction of Highly Active Antiretroviral Therapy (HAART)
JNNP 69:376-380, Maschke,M. et al, 2000
Relation Between Cholinesterase Inhibitor and Pisa Syndrome
Lancet 355:2222, Kwak,Y.T. et al, 2000
Current Clinical Diagnosis in Creutzfeldt-Jakob Disease; Identification of Uncommon Variants
Ann Neurol 48:323-329, Zerr,I. et al, 2000
Leigh Syndrome: Serial MR Imaging and Clinical Follow-Up
AJNR 21:1502-1509, Arii,J. & Tanabe,Y., 2000
Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies
NEJM 343:847-855, Verning,S. et al, 2000
Analysis of EEG and CSF 14-3-3 proteins as adis to the diagnosis of Creutzfeldt-Jakob Disease
Neurol 55:811-815, Zerr,I. et al, 2000
Immunization for Alzheimer's Disease: A Shot in the Arm or a Whiff?
Ann Neurol 48:553-555, Levey,A.I., 2000
Immune Cytopenias as the Presenting Finding in Primary Sjogrens Syndrome
QJM 93:825-829, Schattner,A.,et al, 2000
Alien Hand Sign in Creutzfeldt-Jakob Disease
JNNP 68:103-104, Inzelberg,R.,et al, 2000
Seizures and Creutzfeldt-Jakob Disease
NCMJ 60:108-109, Cokgor,I.,et al, 1999
Creutzfeldt-Jakob Disease Presenting as Complex Partial Status Epilepticus: A Report of Two Cases
JNNP 66:406-407, Rees,J.H.,et al, 1999
Neuro-Ophthalmologic Manifestations of a paraneoplastic Syndrome and Testicular Carcinoma
Neurol 52:864-867, Bennett,J.L.,et al, 1999
Epilepsia Partialis Continua:A New Manifestation of Anti-Hu-Associated Paraneoplastic Encephalomyelitis
Ann Neurol 45:255-258, Shavit,Y.B.,et al, 1999
Diagnostic Criteria for Parkinson Disease
Arch Neurol 56:33-39, Gelb,D.J.,et al, 1999
Spastic Paraparesis after Anaesthesia
Lancet 353:554, Lee,P.,et al, 1999
Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease:International Randomised Controlled
BMJ 318:633-640, 615, Rosler,M.,et al, 1999